Nivolumab | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Nivolumab
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Nivolumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 5 Listed Suppliers

5 API Suppliers
5 Listed Suppliers

DEVELOPMENTS

1591 Drugs in Development

1591 Drugs in Development

FINISHED DOSAGE FORMULATIONS

86 FDF Dossiers, 6 FDA Orange Book, 5 Europe, 3 Canada, 72 Australia

86 FDF Dossiers
6 FDA Orange Book
5 Europe
3 Canada
72 Australia

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Kirsch Pharma, 7 Actylis, 2 BASF, 5 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 3 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
1 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
2 Kirsch Pharma
7 Actylis
2 BASF
5 Gangwal Chemicals
1 Ingredion Pharma Solutions
1 Kerry
2 Microlex e.U
1 Nanjing Bold Chemical
1 Pluviaendo
3 Roquette
6 Seppic
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 14 Parenteral, 12 Chewable & Orodispersible Aids, 11 Solubilizers, 11 Direct Compression, 10 Taste Masking, 7 Disintegrants & Superdisintegrants, 4 Co-Processed Excipients, 3 Thickeners and Stabilizers, 3 Granulation, 3 Topical, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 2 Film Formers & Plasticizers, 2 Controlled & Modified Release, 1 API Stability Enhancers, 1 Rheology Modifiers

17 Fillers, Diluents & Binders
14 Parenteral
12 Chewable & Orodispersible Aids
11 Solubilizers
11 Direct Compression
10 Taste Masking
7 Disintegrants & Superdisintegrants
4 Co-Processed Excipients
3 Thickeners and Stabilizers
3 Granulation
3 Topical
3 Surfactant & Foaming Agents
3 Emulsifying Agents
2 Film Formers & Plasticizers
2 Controlled & Modified Release
1 API Stability Enhancers
1 Rheology Modifiers

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 622 News #PharmaBuzz

3 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
622 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 4 Regulatory FDF Prices, 22 Annual Reports

2 US Medicaid Prescriptions
4 Regulatory FDF Prices
22 Annual Reports

MARKET PLACE

6 APIs, 5 FDF Dossiers

6 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 1McCarthy Tetrault LLP

02 4McCarthy Tétrault

filter Patent Reset all filters

5 All

01 42607147

02 12877746

filter Product Reset all filters

5 All

01 3NIVOLUMAB

02 2NIVOLUMAB | RELATLIMAB

filter Dosage Reset all filters

5 All

01 5SOLUTION

filter Exp Date Reset all filters

5 All

01 42026-05-02

02 12033-07-02

Product Main Page

01

McCarthy Tetrault LLP

Nivolumab

Peptide Process CMC

Not Confirmed

McCarthy Tetrault LLP

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Brand Name : OPDIVO SC

Patent Number : 2607147

Filing Date : 2006-05-02

Strength per Unit : 120 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

McCarthy Tétrault

Nivolumab

Peptide Process CMC

Not Confirmed

McCarthy Tétrault

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Brand Name : OPDIVO

Patent Number : 2607147

Filing Date : 2006-05-02

Strength per Unit : 40 mg / 4 mL (10 mg / mL)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

McCarthy Tétrault

Nivolumab

Peptide Process CMC

Not Confirmed

McCarthy Tétrault

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Brand Name : OPDIVO

Patent Number : 2607147

Filing Date : 2006-05-02

Strength per Unit : 100 mg / 10 mL (10 mg / mL)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

McCarthy Tétrault

Nivolumab

Peptide Process CMC

Not Confirmed

McCarthy Tétrault

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Brand Name : OPDUALAG

Patent Number : 2607147

Filing Date : 2006-05-02

Strength per Unit : 240mg / 20mL and 80mg / 20mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2026-05-02

Date Granted : 2018-07-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

McCarthy Tétrault

Nivolumab

Peptide Process CMC

Not Confirmed

McCarthy Tétrault

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-02

Date Granted : 2022-07-19

Brand Name : OPDUALAG

Patent Number : 2877746

Filing Date : 2013-07-02

Strength per Unit : 240mg / 20mL and 80mg / 20mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2033-07-02

Date Granted : 2022-07-19

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!